Curriculum for optical diagnosis training in Europe: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement.


Journal

Endoscopy
ISSN: 1438-8812
Titre abrégé: Endoscopy
Pays: Germany
ID NLM: 0215166

Informations de publication

Date de publication:
10 2020
Historique:
pubmed: 4 9 2020
medline: 16 2 2021
entrez: 4 9 2020
Statut: ppublish

Résumé

This manuscript represents an official Position Statement of the European Society of Gastrointestinal Endoscopy (ESGE) aiming to guide general gastroenterologists to develop and maintain skills in optical diagnosis during endoscopy. In general, this requires additional training beyond the core curriculum currently provided in each country. In this context, ESGE have developed a European core curriculum for optical diagnosis practice across Europe for high quality optical diagnosis training. 1:  ESGE suggests that every endoscopist should have achieved general competence in upper and/or lower gastrointestinal (UGI/LGI) endoscopy before commencing training in optical diagnosis of the UGI/LGI tract, meaning personal experience of at least 300 UGI and/or 300 LGI endoscopies and meeting the ESGE quality measures for UGI/LGI endoscopy. ESGE suggests that every endoscopist should be able and competent to perform UGI/LGI endoscopy with high definition white light combined with virtual and/or dye-based chromoendoscopy before commencing training in optical diagnosis. 2:  ESGE suggests competency in optical diagnosis can be learned by attending a validated optical diagnosis training course based on a validated classification, and self-learning with a minimum number of lesions. If no validated training course is available, optical diagnosis can only be learned by attending a non-validated onsite training course and self-learning with a minimum number of lesions. 3:  ESGE suggests endoscopists are competent in optical diagnosis after meeting the pre-adoption and learning criteria, and meeting competence thresholds by assessing a minimum number of lesions prospectively during real-time endoscopy. ESGE suggests ongoing in vivo practice by endoscopists to maintain competence in optical diagnosis. If a competent endoscopist does not perform in vivo optical diagnosis on a regular basis, ESGE suggests repeating the learning and competence phases to maintain competence.Key areas of interest were optical diagnosis training in Barrett's esophagus, esophageal squamous cell carcinoma, early gastric cancer, diminutive colorectal lesions, early colorectal cancer, and neoplasia in inflammatory bowel disease. Condition-specific recommendations are provided in the main document.

Identifiants

pubmed: 32882737
doi: 10.1055/a-1231-5123
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

899-923

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

M. Arvanitakis has received lecture fees from Olympus (2019 – 2020). R. Bisschops has received research support, speaker’s and consultancy fees from Medtronic, Cook, Pentax, and Fujifilm (2009 – 2020), he has also received consultancy and speaker’s fees from Norgine, GI supply, Medivators, and Boston Scientific (2009 – 2020). E. Coron received speaker’s fees or congress invitations from Fujifilm (2016 – 2019), and speaker’s fees from Olympus (2016, 2017). E. Dekker received a research grant from Fujifilm, consulting fees for medical advice from Tillots (2018), Olympus (2019), Fujifilm (2017), GI Supply (2018 to present), and CPP-FAP (2019), and speaker’s fees from Olympus (2018), Roche (2016, 2018), and GI Supply (2019); she has received equipment on loan from Fujifilm (2017 to present). M. Dinis-Ribeiro received a research grant from Fujifilm (2019 to present) and a teaching grant from Olympus (2019 to present); he is also co-editor in-chief of

Auteurs

Evelien Dekker (E)

Department of Gastroenterology and Hepatology, Amsterdam University Medical Centre, location Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.

Britt B S L Houwen (BBSL)

Department of Gastroenterology and Hepatology, Amsterdam University Medical Centre, location Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.

Ignasi Puig (I)

Digestive Diseases Department, Althaia Xarxa Assistencial Universitària de Manresa, Manresa, Spain.
Department of Medicine, Facultat de Ciències de la Salut, Universitat de Vic-Universitat Central de Catalunya (UVic-UCC), Manresa, Spain.

Marco Bustamante-Balén (M)

Gastrointestinal Endoscopy Unit, Digestive Diseases Department, La Fe Polytechnic University Hospital, Valencia, Spain.
Gastrointestinal Endoscopy Research Group, La Fe Health Research Institute, Valencia, Spain.

Emmanuel Coron (E)

Institut des Maladies de l'Appareil Digestif (IMAD), CHU Nantes, Université Nantes, Nantes, France.

Daniela E Dobru (DE)

Gastroenterology Department, County Hospital Mures, Targu Mures, Romania.

Roman Kuvaev (R)

Endoscopy Department, Yaroslavl Regional Cancer Hospital, Yaroslavl, Russian Federation.
Department of Gastroenterology, Faculty of Additional Professional Education, Pirogov Russian National Research Medical University, Moscow, Russian Federation.

Helmut Neumann (H)

Department of Medicine I, University Medical Center Mainz, Mainz, Germany.

Gavin Johnson (G)

Department of Gastroenterology, University College London Hospitals, London, UK.

Pedro Pimentel-Nunes (P)

Gastroenterology Department, Portuguese Oncology Institute of Porto, Porto, Portugal.
Center for Research in Health Technologies and Information Systems (CINTESIS), Faculty of Medicine, University of Porto, Porto, Portugal.
Surgery and Physiology Department, Faculty of Medicine of the University of Porto, Porto, Portugal.

David S Sanders (DS)

Academic Unit of Gastroenterology, Royal Hallamshire Hospital, Sheffield, UK.

Mario Dinis-Ribeiro (M)

Gastroenterology Department, Portuguese Oncology Institute of Porto, Porto, Portugal.
Center for Research in Health Technologies and Information Systems (CINTESIS), Faculty of Medicine, University of Porto, Porto, Portugal.

Marianna Arvanitakis (M)

Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, Erasme University Hospital, Brussels, Belgium.

Thierry Ponchon (T)

Gastroenterology Division, Hôpital Edouard Herriot, Lyon, France.

James E East (JE)

Translational Gastroenterology Unit, Nuffield Department of Medicine, Experimental Medicine Division, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Oxford National Institute for Health Research Biomedical Research Centre, University of Oxford, Oxford, UK.

Raf Bisschops (R)

Department of Gastroenterology and Hepatology, Catholic University of Leuven (KUL), TARGID, University Hospital Leuven, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH